Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
68Ga-NOTA-MW70
- Development stage
- Unknown
- Lead developer
- Huashan Hospital
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Peptides
- Administration
- Intravenous
01
Overview
68Ga-NOTA-MW70 is a radiopharmaceutical diagnostic imaging agent developed by Huashan Hospital, Fudan University, for the detection and characterization of malignant renal tumors, specifically renal cell carcinoma (RCC). The agent consists of the positron-emitting radioisotope Gallium-68 (68Ga) chelated by 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) and conjugated to MW70, a targeting moiety specific for CD70 (Cluster of Differentiation 70). CD70 is a member of the tumor necrosis factor (TNF) superfamily that is highly expressed in various malignancies, including clear cell renal cell carcinoma (ccRCC), while having limited expression in normal tissues. By binding to CD70, 68Ga-NOTA-MW70 allows for non-invasive PET/CT imaging to evaluate quantitative uptake metrics and diagnostic performance, potentially aiding in the staging and management of renal cancer.
- Other names
- [68Ga]Ga-NOTA-MW7068Ga-labeled NOTA-MW70
02
Targets
CD70 (Cluster of Differentiation 70)
Beyond the preview
Go deeper on 68Ga-NOTA-MW70.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 68Ga-NOTA-MW70.